Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
102last 24h
3125last 7d
511● bullish (7d)
311● bearish (7d)
227publishers
24/7 Wall St.42d agoneutral
Eli Lilly Just Won FDA Approval for a Once Weekly Insulin and the Stock Is Knocking on $1,200Simply Wall St.44d agobullish
Eli Lilly (LLY) Wins Two FDA Approvals And A $3.35 Billion Drug AllianceSimply Wall St.69d agoneutral
Eli Lilly (LLY) Stock May Be 30% Undervalued Despite Fresh FDA ApprovalThe Wall Street Journal76d agoneutral
FDA Approves Alzheimer’s Blood Test Developed by Roche and Eli LillyPharmaceutical Technology87d agobearish
Eli Lilly cracks down on illicit weight loss drug trade with US lawsuitsBioPharma Dive88d agobearish
Lilly files six lawsuits in bid to shut down ‘black market’ for retatrutideBioPharma Dive108d agoneutral
Lilly, with new data, to seek FDA approval of obesity drug retatrutideSimply Wall St.110d agobearish
Is Eli Lilly (LLY) Undervalued After Novo Nordisk’s GLP 1 Advertising Lawsuit?Stocktwits110d agobearish
Novo Nordisk Lawsuit Against Eli Lilly: Wegovy Maker Alleges Misleading Zepbound, Mounjaro AdsSimply Wall St.116d agobullish
Eli Lilly (LLY) Wins Full FDA Approval For Retevmo In Broader CancersInsider Monkey144d agoneutral
FDA Approves New Eight-Week Maintenance Dosing Regimen for Eli Lilly’s (LLY) EBGLYSS